Preoperative chemotherapy with weekly docetaxel plus low-dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus

Author： Yoshida Takahiro  

Publisher： Springer Publishing Company

ISSN： 1612-9059

Source： Esophagus, Vol.7, Iss.2, 2010-06, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

By  

Liver Cancer, Vol. 4, Iss. 4, 2015-0 ,pp. : 263-273

Karger

Access to resources Recommend Favorite

Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro  

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

By Ardizzoia A.  

Lung, Vol. 182, Iss. 1, 2004-01 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite

Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer

By  

Digestion, Vol. 83, Iss. 3, 2011-01 ,pp. : 146-152

Karger

Access to resources Recommend Favorite

Case series of preoperative triplet-regimen (docetaxel, CDDP and 5-fluorouracil) for borderline resectable T4 thoracic esophageal carcinoma

By Hamamoto Yasuo   Onodera Kei   Saito Mayuko   Akutsu Noriyuki   Inoue Koichi   Kobayashi Nozomu   Kuroki Yoshihito   Matsushita Naoyuki   Katano Susumu   Shimizu Hideaki  

Esophagus, Vol. 10, Iss. 4, 2013-12 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite